ARIA
Library/metabolic/AOD-9604 + GHRP Stack

AOD-9604 + GHRP Stack

Not FDA Approved✓ WADA Permitted
metabolic◆EmergingGH fragment + GHRP stack

Not a single peptide — this entry documents the clinical stack of AOD-9604 (GH fragment 176-191) combined with a GHRP (typically Ipamorelin). The combination provides both direct fat metabolism signaling (AOD-9604) and GH pulse amplification (GHRP) for enhanced body composition results.

Confidence
70%
Half-Life varies
Cost ~$550/mo
Quick Reference
Routesubcutaneous
MechanismAOD-9604 provides direct lipolytic signaling via GH fragment 176-191. GHRP ampli...
Reviewed2026-06-08

Mechanism of Action

AOD-9604 provides direct lipolytic signaling via GH fragment 176-191. GHRP amplifies natural GH release via ghrelin receptor activation. Combined mechanism targets both fat metabolism and recovery/anabolism.

Dosing Protocol

AOD-9604: 300mcg daily + GHRP: 200mcg nightly. Cycle 12-16 weeks.

Adverse Effects

Combined side effects of both peptidesHunger (from GHRP)Injection site reactions

Contraindications

  • Pregnancy
  • Active malignancy
  • Diabetes (monitor glucose)

Storage

Refrigerate both peptides 2-8°C.